{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:32:47Z","timestamp":1761514367324,"version":"3.40.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","geriatriconcology.net","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jgo.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T07:46:53Z","timestamp":1553413613000},"page":"573-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patterns of care and survival of older patients with malignant pleural mesothelioma"],"prefix":"10.1016","volume":"10","author":[{"given":"Anthony","family":"Linton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prunella","family":"Blinman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8405-9688","authenticated-orcid":false,"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2019.02.013_bb0005","series-title":"Cancer Series No 90 Cat no CAN 88","article-title":"Cancer in Australia: an overview 2014","author":"Australian Institute of Health and Welfare","year":"2015"},{"key":"10.1016\/j.jgo.2019.02.013_bb0010","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.ejca.2015.08.027","article-title":"The effects of age on health-related quality of life in cancer populations: a pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients","volume":"51","author":"Quinten","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jgo.2019.02.013_bb0015","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1200\/JCO.2007.12.5435","article-title":"Lung Cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database","volume":"25","author":"Owonikoko","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lungcan.2008.10.020","article-title":"Lung cancer in patients aged 80 years and over","volume":"65","author":"Satoh","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jgo.2019.02.013_bb0025","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2004.02.175","article-title":"Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration","volume":"22","author":"Talarico","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0030","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1200\/JCO.2011.41.1140","article-title":"Effect of adjuvant chemotherapy on survival of patients with stage III Colon Cancer diagnosed after age 75 years","volume":"30","author":"Sanoff","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0035","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1634\/theoncologist.2008-0061","article-title":"Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal Cancer patients in the community oncology setting","volume":"13","author":"McKibbin","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2019.02.013_bb0040","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0045","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma Avastin cisplatin Pemetrexed study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2019.02.013_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1183\/09031936.00153611","article-title":"Population-based survival for malignant mesothelioma after introduction of novel chemotherapy","volume":"40","author":"Damhuis","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgo.2019.02.013_bb0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/bjc.2014.312","article-title":"Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey","volume":"111","author":"Ceresoli","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgo.2019.02.013_bb0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6604442","article-title":"Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials","volume":"99","author":"Ceresoli","year":"2008","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.jgo.2019.02.013_bb0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cllc.2016.03.002","article-title":"Impact of age on long-term outcomes of surgery for malignant pleural mesothelioma","volume":"17","author":"Yang","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jgo.2019.02.013_bb0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.lungcan.2015.05.014","article-title":"Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England","volume":"89","author":"Damhuis","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jgo.2019.02.013_bb0075","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/bjc.2014.478","article-title":"Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales","volume":"111","author":"Linton","year":"2014","journal-title":"Br J Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.jgo.2019.02.013_bb0080","doi-asserted-by":"crossref","first-page":"v31","DOI":"10.1093\/annonc\/mdv199","article-title":"Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Baas","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0085","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"van Zandwijk","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jgo.2019.02.013_bb0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PAT.0000000000000250","article-title":"Loss of expression of BAP1 predicts longer survival in mesothelioma","volume":"47","author":"Farzin","year":"2015","journal-title":"Pathology."},{"key":"10.1016\/j.jgo.2019.02.013_bb0095","first-page":"261","article-title":"Geriatric assessment for oncologists","volume":"12","author":"Korc-Grodzicki","year":"2015","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.jgo.2019.02.013_bb0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/0284186X.2013.840741","article-title":"The effect of a geriatric evaluation on treatment decisions for older cancer patients--a systematic review","volume":"53","author":"Hamaker","year":"2014","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2019.02.013_bb0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jgo.2018.03.014","article-title":"The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients - a systematic review","volume":"9","author":"Hamaker","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0110","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0115","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/annonc\/mdu052","article-title":"Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review","volume":"25","author":"Versteeg","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0120","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment and Management of Vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology","volume":"36","author":"Mohile","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0125","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0130","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer."},{"key":"10.1016\/j.jgo.2019.02.013_bb0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12094-012-0782-6","article-title":"Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians","volume":"14","author":"Giron\u00e9s","year":"2012","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jgo.2019.02.013_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.lungcan.2016.02.009","article-title":"Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer","volume":"95","author":"Moth","year":"2016","journal-title":"Lung Cancer"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406818304259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406818304259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T07:18:43Z","timestamp":1560928723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406818304259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1879406818304259"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2019.02.013","relation":{},"ISSN":["1879-4068"],"issn-type":[{"type":"print","value":"1879-4068"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of care and survival of older patients with malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}